Validic, Sutter Health partnership tests data transfer of wearables

Validic and Sutter Health have partnered together to conduct a pilot project to see how patient-generated health data (PGHD) can be shown to improve patient care and outcomes.

The collaboration focuses on the using Sutter’s Mpower app on patient smartphones and Validic’s VitaSnap to transfer data to provide patient data to improve efficiency when transferring information.

Patients with diabetes can especially benefit from remote monitoring wearables that can measure blood sugar and blood pressure. The data can then be sent to the patient’s physician, who can then alert the patient of an emergency and provide immediate care if needed.

The partnership enrolled patients from Sutter Health with Type II diabetes and gave them the Mpower app, which can sync with multiple devices that measure glucose levels, blood pressure and level of activity. The app then calculates the data in visual representations to motivate them to stay on track with their care and alert physicians when an emergency is detected.

 

 

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.